Results 241 to 250 of about 205,631 (301)

Impact of Negative Prostate-specific Membrane Antigen Positron Emission Tomography on the Decision to Perform a Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- to High-risk Prostate Cancer Patients: Results of an International Survey. [PDF]

Eur Urol Open Sci
Zattoni F, Rajwa P, Kasivisvanathan V, Sanchez LR, Fazekas T, Preisser F, Kesch C, Martini A, Reitano G, Sigle A, Olivier J, Nicoletti R, Bernardino R, Heidegger I, Bianchi L, Bauckneht M, Giganti F, Giesen A, Soeterik T, van den Bergh R, Rivas JG, Dal Moro F, Russo GI, Gandaglia G, Marra G.   +24 more
europepmc   +1 more source

A guide to the types, structures, and multifaceted functions of matrix metalloproteinases in cancer

The FEBS Journal, EarlyView.
Matrix metalloproteinases (MMPs) orchestrate cancer progression and metastasis through proteolytic and non‐proteolytic actions. By remodeling the tumor microenvironment, enhancing growth factor availability, and modulating cell behavior, MMPs promote proliferation, migration or invasion, and epithelial‐to‐mesenchymal transition. Alongside extracellular
Zoi Piperigkou, Sylvia Mangani, Spyros Kremmydas, Nikolaos E. Koletsis, Nikos K. Karamanos   +4 more
wiley   +1 more source

Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma. [PDF]

Cancers (Basel)
Kunte SC, Holzgreve A, Unterrainer M, Zahner J, Schmid HP, Schöll M, Blajan I, Sheikh GT, Mehrens D, Casuscelli J, Tamalunas AJ, Werner RA, Stief CG, Staehler M, Unterrainer LM.   +14 more
europepmc   +1 more source

An update on the landscape of collagen bioactive fragments

The FEBS Journal, EarlyView.
The remodeling of the extracellular matrix releases collagen bioactive fragments, which exert molecular functions and regulate numerous biological processes via several signaling pathways. Here, we summarize the latest findings describing the roles of major bioactive fragments from collagens I, IV, VI, and XVIII in various physiological and ...
Sylvie Ricard‐Blum, Julie Fradette
wiley   +1 more source

Optimizing salvage radiotherapy in prostate cancer: the emerging role of prostate-specific membrane antigen positron emission tomography/computed tomography. [PDF]

Transl Androl Urol
Gonzalez Del Portillo E, López-Campos F, Sargos P, Couñago F.   +3 more
europepmc   +1 more source

Prostate‐specific membrane antigen (PSMA)‐PET‐avid prostate cancers show stronger PSMA immunohistochemistry staining on biopsy cores

BJU International, EarlyView.
Jonathon Carll, Henry Yen‐Cheng Pan, Nathan Lawrentschuk, Andrew Ryan   +3 more
wiley   +1 more source

Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study). [PDF]

EJNMMI Res
Binzaqr S, Kryza D, Giraudet AL, Bernhard JC, Gross-Goupil M, Yacoub M, Margue G, Hindié E, Morgat C.   +8 more
europepmc   +1 more source

Prostate-Specific Membrane Antigen-Targeted Imaging and Its Correlation with HOXB13 Expression. [PDF]

J Nucl Med
Angappulige DH, Barashi NS, Pickersgill N, Weimholt C, Luo J, Shadmani G, Tarcha Z, Rayamajhi S, Mahajan NP, Andriole GL, Siegel BA, Kim EH, Mahajan K.   +12 more
europepmc   +1 more source

The potential of generative AI with prostate-specific membrane antigen (PSMA) PET/CT: challenges and future directions. [PDF]

Med Rev (2021)
Islam MZ, Spiro E, Yap PT, Gorin MA, Rowe SP.   +4 more
europepmc   +1 more source